Mitoxantrone in Combination with a DNA-PK Inhibitor: Possible Therapy of Promyelocytic Leukaemia Resistant Forms Cited by

Fol. Biol. 2011, 57, 200-205

https://doi.org/10.14712/fb2011057050200

Mitoxantrone in Combination with a DNA-PK Inhibitor: Possible Therapy of Promyelocytic Leukaemia Resistant Forms

V. Mikusová¹, A. Tichý¹, M. Řezáčová², Jiřina Vávrová¹

¹Department of Radiobiology, Faculty of Military Health Sciences in Hradec Králové, University of Defence in Brno, Hradec Králové, Czech Republic
²Department of Medical Biochemistry, Faculty of Medicine in Hradec Králové, Charles University in Prague, Hradec Králové, Czech Republic

Received March 2011
Accepted May 2011

Crossref Cited-by Linking

Mishra Saket V., Banerjee Archisman, Sarkar Debashmita, Thangarathnam Vishnuvarthan, Bagal Bhausaheb, Hasan Syed K., Dutt Shilpee: DNA-PKcs-mediated transcriptional regulation of TOP2B drives chemoresistance in acute myeloid leukemia. Journal of Cell Science 2024, 137. <https://doi.org/10.1242/jcs.261931>
Vávrová Ji\u0159ina, Zárybnická L., Jo\u0161t P., Tichý A., \u0158ezá\u010dová M., \u0160inkorová Z., Pejchal J.: Comparison of the Radiosensitizing Effect of ATR, ATM and DNA-PK Kinase Inhibitors on Cervical Carcinoma Cells. Fol. Biol. 2016, 62, 167. <https://doi.org/10.14712/fb2016062040167>
Andrs Martin, Korabecny Jan, Jun Daniel, Hodny Zdenek, Bartek Jiri, Kuca Kamil: Phosphatidylinositol 3-Kinase (PI3K) and Phosphatidylinositol 3-Kinase-Related Kinase (PIKK) Inhibitors: Importance of the Morpholine Ring. J. Med. Chem. 2015, 58, 41. <https://doi.org/10.1021/jm501026z>
Novotná Eva, Tichý Ale\u0161, Pejchal Jaroslav, Luká\u0161ová Emílie, \u0160alovská Barbora, Vávrová Ji\u0159ina: DNA-dependent protein kinase and its inhibition in support of radiotherapy. International Journal of Radiation Biology 2013, 89, 416. <https://doi.org/10.3109/09553002.2013.767993>